These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 9578089

  • 1. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA, Oudejans JJ, van den Brule AJ, Kluin PM, Horstman A, Ossenkoppele GJ, van Heerde P, Jiwa M, Meijer CJ.
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [Abstract] [Full Text] [Related]

  • 2. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P, Niewiadomska H, Błonski JZ, Robak T, Krykowski E.
    Neoplasma; 1998 Apr; 45(3):140-7. PubMed ID: 9717525
    [Abstract] [Full Text] [Related]

  • 3. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
    Rassidakis GZ, Medeiros LJ, McDonnell TJ, Viviani S, Bonfante V, Nadali G, Vassilakopoulos TP, Giardini R, Chilosi M, Kittas C, Gianni AM, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH.
    Clin Cancer Res; 2002 Feb; 8(2):488-93. PubMed ID: 11839668
    [Abstract] [Full Text] [Related]

  • 4. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
    Oudejans JJ, Kummer JA, Jiwa M, van der Valk P, Ossenkoppele GJ, Kluin PM, Kluin-Nelemans JC, Meijer CJ.
    Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
    [Abstract] [Full Text] [Related]

  • 5. [Mummified Hodgkin and Reed-Sternberg cells in EBV positive and EBV negative Hodgkin's lymphomas, Bcl-2 positivity and evaluation of survival].
    Macák J, Bertová M.
    Vnitr Lek; 2001 Mar; 47(3):151-5. PubMed ID: 15635876
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution.
    Smolewski P, Robak T, Krykowski E, Blasiñska-Morawiec M, Niewiadomska H, Pluzanska A, Chmielowska E, Zambrano O.
    Clin Cancer Res; 2000 Mar; 6(3):1150-60. PubMed ID: 10741746
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.
    Oudejans JJ, Jiwa NM, Meijer CJ.
    J Pathol; 1997 Apr; 181(4):353-6. PubMed ID: 9196428
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
    Allal AS, Waelchli L, Bründler MA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6489-96. PubMed ID: 14695153
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.
    Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL.
    Clin Cancer Res; 1996 Dec 15; 2(12):2015-22. PubMed ID: 9816161
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
    Chapman AL, Rickinson AB, Thomas WA, Jarrett RF, Crocker J, Lee SP.
    Cancer Res; 2001 Aug 15; 61(16):6219-26. PubMed ID: 11507075
    [Abstract] [Full Text] [Related]

  • 12. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
    Bottini A, Berruti A, Bersiga A, Brizzi MP, Brunelli A, Gorzegno G, DiMarco B, Aguggini S, Bolsi G, Cirillo F, Filippini L, Betri E, Bertoli G, Alquati P, Dogliotti L.
    Clin Cancer Res; 2000 Jul 15; 6(7):2751-8. PubMed ID: 10914720
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK, Jung JT, Kim DH, Kim JG, Kwak EK, Park Ti, Shin DG, Sohn KR, Lee KB.
    Am J Hematol; 2003 Jun 15; 73(2):101-7. PubMed ID: 12749011
    [Abstract] [Full Text] [Related]

  • 14. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H, Berger C, McQuain C, Rothenberger S, Bachmann E, Martin J, Esslinger C, Drexler HG, Cai YC, Quesenberry PJ, Odermatt BF.
    Oncogene; 1999 Nov 25; 18(50):7161-7. PubMed ID: 10597317
    [Abstract] [Full Text] [Related]

  • 15. Immunoreactivities of Reed-Sternberg cells and their variants in the sequential biopsy of Hodgkin's disease.
    Ohsawa M, Aozasa K, Ikeda H.
    Mod Pathol; 1993 Jul 25; 6(4):457-62. PubMed ID: 8415592
    [Abstract] [Full Text] [Related]

  • 16. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
    Vasef MA, Alsabeh R, Medeiros LJ, Weiss LM.
    Am J Clin Pathol; 1997 Jul 25; 108(1):54-9. PubMed ID: 9208978
    [Abstract] [Full Text] [Related]

  • 17. [Localization of apoptosis-antagonizing bcl-2 translated product in Hodgkin's disease].
    Chen XQ, Wang WL, Huang GS.
    Zhonghua Yi Xue Za Zhi; 1994 Oct 25; 74(10):618-20, 647. PubMed ID: 7842340
    [Abstract] [Full Text] [Related]

  • 18. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A, van Imhoff GW, Karim-Kos HE, van den Berg A, te Meerman GJ, Niens M, Nolte IM, Bastiaannet E, Schaapveld M, Vellenga E, Poppema S.
    J Clin Oncol; 2007 Jul 20; 25(21):3101-8. PubMed ID: 17536082
    [Abstract] [Full Text] [Related]

  • 19. PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease.
    Xerri L, Parc P, Bouabdallah R, Camerlo J, Hassoun J.
    J Pathol; 1995 Feb 20; 175(2):189-94. PubMed ID: 7738714
    [Abstract] [Full Text] [Related]

  • 20. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 20; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.